izpis_h1_title_alt

Vpliv antifosfolipidnih protiteles na vnetni in adhezijski profil monocitov
ID Štucin, Neža (Author), ID Čučnik, Saša (Mentor) More about this mentor... This link opens in a new window, ID Žigon, Polona (Comentor)

.pdfPDF - Presentation file, Download (2,17 MB)
MD5: 94F4A5D332EEEF6EFA83DE14D3E11D3A

Abstract
Antifosfolipidni sindrom je sistemska avtoimunska bolezen, za katero so značilne žilne tromboze in/ali zapleti v nosečnosti ob stalni prisotnosti antifosfolipidnih protiteles. Antifosfolipidna protitelesa se preko interakcij s trombociti, endotelnimi celicami in monociti vpletajo v patogenezo tromboze pri antifosfolipidnem sindromu. Posledica tovrstnih interakcij so spremembe v fenotipu tarčnih celic, ki se kaže v povečanem izražanju protrombotičnih molekul. Pri monocitih pride do povečanega izražanja vnetnih citokinov in tkivnega faktorja, pri endotelnih celicah pa se poleg tega poveča tudi izražanje adhezijskih molekul, kar vzpodbudi interakcije endotelnih celic z monociti. Zelo malo študij se osredotoča na vprašanje, ali antifosfolipidna protitelesa vzpodbujajo interakcije monocitov z endotelijem tudi preko vpliva na adhezijske molekule izražene na monocitih. Namen naše raziskave je zato bil, da poleg vpliva antifosfolipidnih protiteles na izražanje vnetnih citokinov in tkivnega faktorja, raziščemo še vpliv antifosfolipidnih protiteles na izražanje adhezijskih molekul na monocitih. Tako celice THP1 kot tudi iz krvi izolirane monocite smo stimulirali s frakcijami IgG bolnikov z antifosfolipidnim sindromom ob sočasni prisotnosti lipopolisaharida in dodatku protrombina. Najprej smo s poskusi na celicah THP1 preko merjenja količine izločenega tumor nekrotičnega dejavnika α v celično okolje opredelili ustrezne pogoje stimulacije pri kateri pride do aktivacije celic. Kasneje smo, ob uporabi opredeljenih pogojev stimulacije, ovrednotili še količine drugih izločenih vnetnih citokinov (tumor nekrotični dejavnik α, interlevkin 6) v okolje celic THP1 in monocitov. Ob enem smo na nivoju mRNA merili spremembe v izražanju genov za vnetne citokine (tumor nekrotični dejavnik α, interlevkin 6, 1β, 8) ter gena za tkivni faktor v celicah THP1. Izražanje adhezijskih molekul (CD49d, CD11b, CD62L) na površini monocitov smo določili s pretočno citometrijo. Naši rezultati kažejo, da antifosfolipidna protiteles ob prisotnosti lipopolisaharida aktivirajo monocitne celice, ob čemer pride do povečanega izražanja vnetnih citokinov, tkivnega faktorja in do spremenjenega izražanja adhezijskih molekul. V celicah THP1 smo izmerili povečanje izražanja genov za tumor nekrotični dejavnik α in interlevkine 6, 1β, 8. Rezultate o povečanem izražanju tumor nekrotičnega dejavnika α in interlevkina 6 smo dodatno dokazali tudi na proteinskem nivoju, ko smo njune povišane vrednosti izmerili v celičnem okolju celic THP1 in monocitov. V celicah THP1 smo izmerili tudi povečano izražanje gena za tkivni faktor. Na monocitih smo izmerili spremenjen profil adhezijskih molekul, in sicer povečano izražanje CD49d in CD62L ter zmanjšano izražanje CD11b.

Language:Slovenian
Keywords:antifosfolipidni sindrom, antifosfolipidna protitelesa, vnetni citokini, tkivni faktor, adhezijske molekule
Work type:Master's thesis/paper
Organization:FFA - Faculty of Pharmacy
Year:2022
PID:20.500.12556/RUL-137567 This link opens in a new window
Publication date in RUL:22.06.2022
Views:826
Downloads:149
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Influence of antiphospholipid antibodies on the monocyte inflammatory and adhesion profile
Abstract:
Antiphospholipid syndrome is a systemic autoimmune disease characterized by vascular thrombosis and/or complications in pregnancy in the constant presence of antiphospholipid antibodies. Antiphospholipid antibodies are involved in the pathogenesis of thrombosis in antiphospholipid syndrome through interactions with platelets, endothelial cells and monocytes. Such interactions result in changes in the target cell phenotype, which turns into prothrombotic. In monocytes and endothelial cells, these changes show as increased expression of inflammatory cytokines and tissue factor. In endothelial cells, the expression of adhesion molecules is also increased, which promotes interactions of endothelial cells with monocytes. Very few studies focused on the question whether these interactions are also promoted trough increased expression of adhesion molecules on the monocytes. The purpose of our study was therefore that in addition to the effect of antiphospholipid antibodies on the expression of inflammatory cytokines and tissue factor, we also investigate the effect of antiphospholipid antibodies on the expression of adhesion molecules on monocytes. THP1 cells as well as monocytes isolated from blood were stimulated with IgG fractions of patients with antiphospholipid syndrome in the presence of lipopolysaccharide and the addition of prothrombin. First, we determined the appropriate stimulation conditions by which the activation of cells is achieved through measuring the amount of tumor necrotic factor α secreted into the cell environment. Later, using the defined stimulation conditions, the effects of antiphospholipid antibodies were evaluated. We measured secreted proinflammatory cytokines (tumor necrotic factor α, interleukin 6) by THP1 cells and monocytes, changes in the expression of genes for proinflammatory cytokines (tumor necrotic factor α, interleukin 6, 1β, 8) and tissue factor in THP1 cells and changes in the expressions of adhesion molecules (CD49d, CD11b, CD62L) on the surface of monocytes by flow cytometry. Our results show that antiphospholipid antibodies in the presence of lipopolysaccharide activate monocytic cells, resulting in the increased expression of inflammatory cytokines, tissue factor, and altered expression of adhesion molecules. In THP1 cells, increased gene expression of tumor necrotic factor α and interleukin 6, 1β, 8 was measured. In addition, we measured increased secretion of tumor necrotic factor α and interleukin 6 into the cell environment of THP1 cells and monocytes. In THP1 cells we also measured increased gene expression of tissue factor. An altered profile of adhesion molecules was measured on monocytes, namely increased expression of CD49d and CD62L and decreased expression of CD11b.

Keywords:antiphospholipid syndrome, antiphospholipid antibodies, inflammatory cytokines, tissue factor, adhesion molecules

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back